Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies

The β-hemoglobinopathies sickle cell anemia and β-thalassemia are the focus of many gene-therapy studies. A key disease parameter is the abundance of globin chains because it indicates the level of anemia, likely toxicity of excess or aberrant globins, and therapeutic potential of induced or exogeno...

Descripción completa

Detalles Bibliográficos
Autores principales: Loucari, Constantinos C., Patsali, Petros, van Dijk, Thamar B., Stephanou, Coralea, Papasavva, Panayiota, Zanti, Maria, Kurita, Ryo, Nakamura, Yukio, Christou, Soteroulla, Sitarou, Maria, Philipsen, Sjaak, Lederer, Carsten W., Kleanthous, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806072/
https://www.ncbi.nlm.nih.gov/pubmed/29325430
http://dx.doi.org/10.1089/hgtb.2017.190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806072/
https://www.ncbi.nlm.nih.gov/pubmed/29325430
http://dx.doi.org/10.1089/hgtb.2017.190

Ejemplares similares